|
Volumn 9, Issue 2, 2008, Pages 109-112
|
Connecting immunology research to public health: Cuban biotechnology
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BCG VACCINE;
CANCER VACCINE;
CYTOKINE;
HAEMOPHILUS INFLUENZAE VACCINE;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
IMMUNOGLOBULIN;
INTERFERON;
MENINGITIS VACCINE;
MONOCLONAL ANTIBODY;
NIMOTUZUMAB;
RECOMBINANT PROTEIN;
VACCINE;
ALLERGIC DISEASE;
AUTOIMMUNE DISEASE;
BIOTECHNOLOGY;
CANCER IMMUNOTHERAPY;
CHRONIC DISEASE;
CLINICAL TRIAL;
COMMUNICABLE DISEASE;
CUBA;
HAIRY CELL LEUKEMIA;
HEALTH CARE ACCESS;
HEALTH EDUCATION;
HUMAN;
IMMUNOLOGY;
INFANT MORTALITY;
INFECTION CONTROL;
INFECTION RATE;
KIDNEY CARCINOMA;
LARYNX PAPILLOMATOSIS;
LIFE EXPECTANCY;
LYMPHOMA;
MELANOMA;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
PUBLIC HEALTH;
TUMOR;
VACCINATION;
ALLERGY AND IMMUNOLOGY;
BIOTECHNOLOGY;
CHILD;
CHILD MORTALITY;
COMMUNICABLE DISEASE CONTROL;
CUBA;
HUMANS;
IMMUNIZATION PROGRAMS;
PUBLIC HEALTH;
RESEARCH;
|
EID: 38349179704
PISSN: 15292908
EISSN: 15292916
Source Type: Journal
DOI: 10.1038/ni0208-109 Document Type: Note |
Times cited : (31)
|
References (20)
|